Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes.
Urien, Saik; Bardin, Christophe; Bader-Meunier, Brigitte; Mouy, Richard; Compeyrot-Lacassagne, Sandrine; Foissac, Franz; Florkin, Benoît; Wouters, Carine; Neven, Bénédicte; Treluyer, Jean-Marc; Quartier, Pierre.
BMC Pharmacol Toxicol
; 14: 40, 2013 Aug 05.
Artigo em Inglês | MEDLINE | ID: mdl-23915458
A novel mutation of interleukin-1 receptor antagonist (IL1RN) in a DIRA patient from Turkey: Diagnosis and treatment.
IL-1 blockade in autoinflammatory syndromes.
Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN.
The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist.
Role of interleukin-1ß in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy.
Autoinflammatory disease reloaded: a clinical perspective.
Schwere Akne bei Autoinflammationskrankheiten.
Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra.
The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome.
Genetically defined autoinflammatory diseases.